HDAC6 is required for invadopodia activity and invasion by breast tumor cells

被引:77
|
作者
Rey, Mercedes [1 ,2 ]
Irondelle, Marie [1 ,2 ]
Waharte, Francois [1 ,3 ]
Lizarraga, Floria [1 ,2 ]
Chavrier, Philippe [1 ,2 ]
机构
[1] Inst Curie, Res Ctr, F-75248 Paris 05, France
[2] CNRS, UMR144, F-75248 Paris 05, France
[3] Inst Curie, CNRS, Cell & Tissue Imaging Facil, PICT IBiSA,UMR 144, F-75248 Paris 05, France
关键词
Invadopodia; Acetylation; Histone deacetylase; HDAC6; Tumor cell invasion; EXTRACELLULAR-MATRIX DEGRADATION; IN-VIVO; BASEMENT-MEMBRANE; CONTACT SITES; CANCER; ACETYLATION; CORTACTIN; METALLOPROTEINASE; MICROTUBULES; DEACETYLASE;
D O I
10.1016/j.ejcb.2010.09.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Invasion across tissue boundaries by metastatic tumor cells depends on the proteolytic degradation of the extracellular matrix, initiated by the formation of invadopodia, actin-driven membrane protrusions with matrix-degradative activity. Yet, mechanisms underlying invadopodia formation remain largely unknown. In this report, we examined the role of the histone deacetylase HDAC6 in invadopodia formation and invasion by breast cancer cells. Using small interfering RNA silencing of protein expression in highly invasive MDA-MB-231 breast adenocarcinoma cells, we show that HDAC6 is required for two-dimensional matrix proteolysis. In addition, we demonstrate that HDAC6 acts as a tubulin and cortactin deacetylase. We also report that the inhibition of HDAC6 by siRNA or treatment with HDAC inhibitor TSA results in a decreased invasion capacity of a three-dimensional type I collagen matrix by MDA-MB-231 cells. These data identify HDAC6 as a critical component of the invasive apparatus of tumor cells, in both two- and three-dimensional matrices. (C) 2010 Elsevier GmbH. All rights reserved.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [41] Brain expression level and activity of HDAC6 protein in neurodegenerative dementia
    Odagiri, Saori
    Tanji, Kunikazu
    Mori, Fumiaki
    Miki, Yasuo
    Kakita, Akiyoshi
    Takahashi, Hitoshi
    Wakabayashi, Koichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 430 (01) : 394 - 399
  • [42] Loss of Deacetylation Activity of Hdac6 Affects Emotional Behavior in Mice
    Fukada, Masahide
    Hanai, Atsuko
    Nakayama, Atsuo
    Suzuki, Takayoshi
    Miyata, Naoki
    Rodriguiz, Ramona M.
    Wetsel, William C.
    Yao, Tso-Pang
    Kawaguchi, Yoshiharu
    PLOS ONE, 2012, 7 (02):
  • [43] HDAC6 Substrate Discovery Using Proteomics-Based Substrate Trapping: HDAC6 Deacetylates PRMT5 to Influence Methyltransferase Activity
    Gomes, Inosha D.
    Ariyaratne, Udana, V
    Pflum, Mary Kay H.
    ACS CHEMICAL BIOLOGY, 2021, 16 (08) : 1435 - 1444
  • [44] Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat.
    Pan, Qingfei
    Zeleke, Tizita
    Chiuzan, Cody
    Onishi, Maika
    Alvarez, Mariano
    Honan, Erin
    Yang, Min
    Chia, Pei Ling
    Mukhopadhyay, Partha
    Kelly, Sean
    Wu, Ruby
    Fenn, Kathleen
    Trivedi, Meghna
    Accordino, Melissa
    Crew, Katherine
    Hershman, Dawn
    Maurer, Matthew
    Jones, Simon
    Califano, Andrea
    Kalinsky, Kevin
    Yu, Jiyang
    Silva, Jose
    CANCER RESEARCH, 2021, 81 (13)
  • [45] Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension
    Lemon, Douglas D.
    Horn, Todd R.
    Cavasin, Maria A.
    Jeong, Mark Y.
    Haubold, Kurt W.
    Long, Carlin S.
    Irwin, David C.
    McCune, Sylvia A.
    Chung, Eunhee
    Leinwand, Leslie A.
    McKinsey, Timothy A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (01) : 41 - 50
  • [46] HDAC6 deacetylates HMGN2 to regulate Stat5a activity and breast cancer growth
    Clevenger, C. V.
    Craig, J. M.
    Fiorillo, A. A.
    Feeney, Y. B.
    Harrell, J. C.
    Medler, T. R.
    CANCER RESEARCH, 2017, 77
  • [47] HDAC6 regulates dental mesenchymal stem cells and osteoclast differentiation
    Wang, Yi
    Shi, Zhi Yun
    Feng, Jin
    Cao, Jun Kai
    BMC ORAL HEALTH, 2018, 18
  • [48] The HDAC6 inhibitor ACY-1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells
    Lee, Dong Hoon
    Won, Hye-Rim
    Ryu, Hyun-Wook
    Han, Jung Min
    Kwon, So Hee
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (02) : 844 - 854
  • [49] HDAC6 SILENCING INHIBITS ANDROGEN RECEPTOR ACTIVITY AND TUMOR GROWTH IN A XENOGRAFT MODEL OF HUMAN PROSTATE CANCER
    Ai, Junkui
    Wang, Yujuan
    Dar, Javid A.
    Liu, Lingqi
    Nelson, Joel B.
    Wang, Zhou
    JOURNAL OF UROLOGY, 2009, 181 (04): : 95 - 95
  • [50] HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth
    Medler, Terry R.
    Craig, Justin M.
    Fiorillo, Alyson A.
    Feeney, Yvonne B.
    Harrell, J. Chuck
    Clevenger, Charles V.
    MOLECULAR CANCER RESEARCH, 2016, 14 (10) : 994 - 1008